A Pilot Study of Pre-Operative, Single-Dose Ipilimumab and/or Cryoablation in Early Stage/Resectable Breast Cancer.
Phase of Trial: Phase I
Latest Information Update: 26 Aug 2016
At a glance
- Drugs Ipilimumab (Primary)
- Indications Early breast cancer
- Focus Adverse reactions
- 26 Aug 2016 Results published in the Clinical cancer research: an official journal of the American Association for Cancer Research
- 14 Dec 2013 Interim results presented at the 36th Annual San Antonio Breast Cancer Symposium.
- 05 Dec 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History